Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
This page is not indexed by search engines while we improve data quality.
Kenall Mfg Co — Human Necessities
Kenall Mfg Co holds 26 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Kenall Mfg Co |
| Technology | Human Necessities |
| Patents in slice | 26 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2023 |
Representative patents
Notable publications linking Kenall Mfg Co to Human Necessities.
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Recent filings
Latest patents from Kenall Mfg Co in Human Necessities.
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Method of providing doses of light sufficient to deactivate dangerous pathogens throughout a volumetric space over a period of time
US-2023051102-A1 · Feb 16, 2023 · US
Related pages
Navigate to parent entity pages.